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coordinate the targeting and growth of
myelin is unknown. Klingseisen et al. find
that oligodendrocytes employ
Neurofascin to prevent myelin
mistargeting to cell bodies and also to
support the stable growth of sheaths
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and mice.Inc.
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Selection of the correct targets for myelination and
regulation of myelin sheath growth are essential for
central nervous system (CNS) formation and func-
tion. Through a genetic screen in zebrafish and com-
plementary analyses in mice, we find that loss of
oligodendrocyte Neurofascin leads to mistargeting
of myelin to cell bodies, without affecting targeting
to axons. In addition, loss of Neurofascin reduces
CNS myelination by impairing myelin sheath growth.
Time-lapse imaging reveals that the distinct myeli-
nating processes of individual oligodendrocytes
can engage in target selection and sheath growth
at the same time and that Neurofascin concomitantly
regulates targeting and growth. Disruption to Caspr,
the neuronal binding partner of oligodendrocyte
Neurofascin, also impairs myelin sheath growth,
likely reflecting its association in an adhesion com-
plex at the axon-glial interface with Neurofascin.
Caspr does not, however, affect myelin targeting,
further indicating that Neurofascin independently
regulates distinct aspects of CNS myelination by in-
dividual oligodendrocytes in vivo.
INTRODUCTION
Myelination in the central nervous system (CNS), by oligoden-
drocytes, starts around birth, and continues into adult life,
with specific axons and circuits myelinated in stereotyped pat-
terns at distinct times. Myelination speeds up nerve impulse
propagation (Seidl, 2014), provides support to axons (Saab
and Nave, 2017) and its dynamic regulation, including by
neuronal activity, may represent a form of experience-driven
nervous system plasticity (Almeida and Lyons, 2017). Although
myelination occurs throughout life, the period during which in-
dividual oligodendrocytes form and grow their myelin sheaths
is, by comparison, very short. Studies in zebrafish and rodents
indicate that oligodendrocytes have a period on the order ofDevelopmental Cell 51, 1–15, Dec
This is an open access article undhours during which they select axons for myelination and
initiate myelin sheath growth (Czopka et al., 2013; Watkins
et al., 2008). During this time, oligodendrocytes extend dy-
namic processes that interact with multiple targets, making
myelin sheaths on specific axons, while retracting from incor-
rect targets, including inappropriate axons and cell bodies (Al-
meida et al., 2018; Baraban et al., 2018; Czopka et al., 2013;
Hines et al., 2015; Mensch et al., 2015). Myelin sheath growth
continues over a days-long period (Auer et al., 2018; Snaidero
et al., 2014), with sheaths remaining stable thereafter (Auer
et al., 2018; Hill et al., 2018; Hughes et al., 2018). Although
recent studies have provided insight into the dynamics of
CNS myelination, the mechanisms by which oligodendrocytes
coordinate myelin targeting and growth remain unclear.
Oligodendrocytes can differentiate and enwrap inert axon and
cell body shaped structures with myelin in the absence of axonal
signals in vitro (Bechler et al., 2015; Lee et al., 2012; Redmond
et al., 2016). Indeed, this default drive to make myelin can lead
to its mistargeting in vivo, as evidenced by the mistargeting of
myelin to cell bodies when its production outweighs axonal de-
mand (Almeida et al., 2018). However, myelin mistargeting is
rare in the healthy nervous system, because myelination is regu-
lated by extrinsic signals. Axonal diameter and neuronal activity
can bias myelination toward specific axons (Bechler et al., 2015;
Goebbels et al., 2017; Hines et al., 2015; Koudelka et al., 2016;
Lee et al., 2012; Mitew et al., 2018; Wake et al., 2015), and inhib-
itory signals help prevent myelination of incorrect targets (Al-
meida, 2018; Klingseisen and Lyons, 2017; Redmond et al.,
2016). Myelin sheath growth is also influenced by extrinsic sig-
nals, as evidenced by stereotyped patterns of myelination along
certain axons (Almeida and Lyons, 2017; Ford et al., 2015; Seidl,
2014), and regulation of sheath length by activity (Etxeberria
et al., 2016; Hines et al., 2015; Koudelka et al., 2016). In addition,
dysregulation of axon-oligodendrocyte adhesion can impair
myelin targeting and sheath growth (Elazar et al., 2019a;
2019b). However, many questions remain as to how oligoden-
drocytes coordinate myelin targeting and growth in vivo. Do indi-
vidual oligodendrocytes first ensure correct myelin targeting and
only subsequently regulate sheath growth, or can the distinct
processes of an individual oligodendrocyte regulate sheath
targeting and growth in parallel? Do oligodendrocytes
employ distinct molecular mechanisms to regulate targetingember 16, 2019 ª 2019 The Author(s). Published by Elsevier Inc. 1
er the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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of myelination?
To better understand mechanisms of myelination, we under-
took an ENU-mutagenesis-based genetic screen in zebrafish.
We identified a mutation in neurofascin b, which caused mistar-
geting ofmyelin to cell bodies and impairedmyelin sheath growth
along axons. Neurofascin B encodes an L1 family immunoglob-
ulin cell adhesionmolecule required by oligodendrocytes for cor-
rect myelin targeting and growth, phenotypes conserved in mice
that lack Neurofascin in oligodendrocytes. Live imaging revealed
that individual oligodendrocytes can regulate myelin targeting
and sheath growth at the same time, in a Neurofascin-dependent
manner. We also found that loss of Caspr, the axonal binding
partner of oligodendrocyteNeurofascin, impaired sheath growth,
likely reflecting their known association in an adhesion complex
at the axon-glial interface (Bhat et al., 2001; Einheber et al.,
1997; Sherman et al., 2005). Caspr disruption did not affect
myelin targeting, indicating thatNeurofascin regulatesmyelin tar-
geting and sheath growth through distinct mechanisms.
RESULTS
Mutation of Zebrafish Neurofascin B Leads to
Mistargeting of CNS Myelin to Cell Bodies
To identify genes that regulate CNS myelination, we carried out
an ENU-mutagenesis-based forward genetic screen using ze-
brafish (STAR Methods). To screen for mutant phenotypes, we
used the transgenic reporter Tg(mbp:EGFP-CAAX), in which
membrane-localized Green Flourescent Protein (GFP) in myeli-
nating glia allows assessment of myelin morphology (Almeida
et al., 2011). We screened zebrafish larvae for disruption to mye-
lination at 5 days post-fertilization (dpf), a time when several cir-
cuits are robustly myelinated (Almeida et al., 2011; Koudelka
et al., 2016).
One of the mutants identified in our screen, ue56, while
morphologically normal (Figures 1A and 1B), exhibited a striking
phenotype, whereby a large number of cell bodies throughout
the CNS were ensheathed by mbp:EGFP-CAAX-labeled mem-
brane (Figures 1C–1E). To identify the mutation responsible for
this phenotype, we performed whole-genome sequencing
(STAR Methods). This revealed genetic linkage of the mutant
phenotype with a region of chromosome 23, in which a C to T
transition was identified, predicted to introduce a premature
STOP codon in the gene neurofascin b (Figures 1F and S1;
STAR Methods).
In mammals, splice-variant isoforms of neurofascin are gener-
ated from a single gene locus. For example, Neurofascin 186 is a
neuron-specific isoform that localizes to nodes of Ranvier, where
it is essential for ion channel clustering (Sherman et al., 2005;
Zonta et al., 2011). Neurofascin 155, in contrast, is a myelinating
glial-specific isoform (Collinson et al., 1998; Tait et al., 2000),
which forms an adhesion complex with axonal Contactin 1 and
Caspr at the paranodal junction (Charles et al., 2002). In contrast
to mammals, zebrafish have two Neurofascin-encoding loci,
neurofascin a and neurofascin b (STAR Methods). neurofascin
a is predicted to encode multiple isoforms, and previous studies
have shown that a neurofascin a product localizes to nodes of
Ranvier (Auer et al., 2018) and is essential for node formation
(Voas et al., 2009). However, a gene encoding a zebrafish Neuro-2 Developmental Cell 51, 1–15, December 16, 2019fascin analogous to the myelinating glial Neurofascin 155 of
mammals has remained elusive. Here we find by sequence align-
ment that neurofascin b (nfascb) is predicted to encode a protein
analogous in domain organization to mammalian Neurofascin
155, in which the extracellular component has six IG domains,
four fibronectin domains but lacks the mucin domain character-
istic of neuronal isoforms (Figure 1G).
Real-time PCR revealed a complete reduction in nfascbmRNA
levels in ue56mutants (Figure S1B), indicative of nonsensemedi-
ated mRNA decay. Therefore, ue56 is an allele that likely results
in a complete loss of Neurofascin B protein. Confirming that
disruption of nfascb leads to mistargeting of myelin to cell
bodies, we found that injection of synthetic mRNA encoding
wild-type nfascb into ue56 mutants reduced the number of
myelinated cell bodies in mutants (Figures S2A, S2B, and S2E).
In addition, knocking down nfascb using a morpholino antisense
oligonucleotide (STAR Methods), led to an almost identical in-
crease in myelinated cell bodies in the CNS as in ue56 mutants
(Figures S2C, S2D, and S2F). Our observations of myelinated
cell bodies in ue56 mutants, the identification of a STOP codon
in nfascb in ue56mutants, rescue of the phenotype with wildtype
nfascb mRNA, and phenocopy by knockdown of nfascb, indi-
cate that Neurofascin B is required for correct myelin targeting
in the zebrafish CNS. From here we designate the ue56 mutant
nfascbue56.
Neurofascin B PreventsMyelination of Cell Bodies in the
CNS but Is Dispensable for Targeting of Myelin to Axons
To further assess the role of Neurofascin B in myelin targeting in
the zebrafish CNS, we imaged myelinating oligodendrocytes in
Tg(cntn1b:mCherry) animals with fluorescently labeled neurons
(Figures 1H and 1I0). These analyses confirmed extensive myeli-
nation of neuronal cell bodies throughout the spinal cord, with
no indication ofmistargeting being specific to any particular ante-
rior-posterior region along theneuraxis (Figures 1Hand1I0).When
we plotted the medio-lateral and dorso-ventral positions of all
myelinated cell bodies in a 3-somite stretch of spinal cord of 11
mutants, they were present at essentially all positions that con-
tained cell bodies, further indicating a general mistargeting of
myelin to cell bodies in the absence of Neurofascin B (Figure 1J).
Our analyses of myelination using Tg(mbp:EGFP-CAAX) indi-
cated that despite the extensive myelination of cell bodies,
myelin sheaths were made on axons located in the same regions
and tracts as controls (Figures 1C and 1D). To better assess
axonal myelination, we turned to electron microscopy (EM).
This confirmed prominent myelination of cell bodies, many of
which were ensheathed with bona fide multilammelar myelin-
like membrane (Figures 2A–2D0) and myelination of the same
axonal tracts in mutants and controls (Figures 2A and 2B). We
have previously shown that in animals with fewer large caliber
axons, myelination of cell bodies can ensue (Almeida et al.,
2018). Therefore, we wanted to assess whether there was a
reduction in large caliber axons in nfascbue56 mutants that might
influence myelin targeting. We saw, however, that the number of
large caliber axons was essentially identical in nfascbue56 mu-
tants and controls (Figures 2E–2I). We did observe, though,
that the proportion of such large caliber axons that was myelin-
ated was reduced by about 40% in nfascbue56 mutants
(Figures 2E–2H and 2J), without any evidence of myelination of
Figure 1. Neurofascin B Is Required for
Myelin Targeting in the Zebrafish CNS
(A and B) Images of wild type (A) and ue56 mutant
(B) larvae at 5 days post-fertilization (dpf), showing
normal morphological development of ue56 mu-
tants. Scale bar, 500 mm.
(C–D0 ) Confocal images of myelin in a wildtype larva
(C and C0) and ue56 mutant (D and D0) at 5dpf,
visualized using Tg(mbp:EGFP-CAAX). Lateral
views, with anterior to the left. (C) and (D) are
maximum intensity projections of z sections taken
through the entire spinal cord, with (C0) and (D0)
being a projection of a subset of z sections centered
closer to the midline in the region where cell bodies
are prominent and myelinated in mutants. Scale
bars, 20 mm.
(E) Quantitation of myelinated cell body number in
wildtype and ue56mutants at 5dpf in a 3 somite long
stretch of spinal cord (wild type median = 2, 25th
percentile 0, 75th percentile 2.5, n = 13 animals,
ue56 median = 53, 25th percentile 46.5, 75th
percentile 62.75, n = 14 animals, p < 0.0001, t test)
(F) Sequence at amino acid positions where the
ue56 mutation generates a stop codon and indica-
tion of the conserved region across species.
(G) Schematic of predicted domain structure of
mouse neurofascin 186, neurofascin 155, and ze-
brafish neurofascin B, with indication of where the
mutation in ue56 mutants resides.
(H–I0) Z projections of confocal images of
neurons (red) andmyelin (green) in a wildtype animal
(H and H0) and nfascbue56 mutant (I and I0), showing
myelin sheaths made on axons (H and I) and mye-
lination of cell bodies in mutants in a region with cell
bodies only (H0 versus I0). Scale bars, 20 mm.
(J) Schematic cross section of the larval zebrafish
spinal cord denoting areas with cell bodies (red) and
myelinated axons (green) (Top panel). Dorso-ventral
and medio-lateral positions of all myelinated cell
bodies (dots) in a 3-somite long stretch of spinal
cord of 11 mutants (bottom panel).
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thickness of myelin sheaths indicated no difference between
wild types and nfascbue56 mutants (Figures 2 K and 2L).
Given these roles for Neurofascin B in CNS myelination, we
also asked how myelination of the peripheral nervous system
(PNS) was affected in nfascbue56 mutants. We assessed myeli-
nation of the posterior lateral line nerve (pLLn) by EM, but this re-
vealed no difference in the number of myelinated axons ormyelin
thickness at 5 dpf (Figure S3). Together our data indicate that
Neurofascin B prevents mistargeting of myelin to cell bodies
and is required for complete myelination of large caliber axons
in the CNS.
Neurofascin Functions in Oligodendrocytes to Mediate
Normal Myelin Targeting
Since Neurofascin B is analogous to themyelinating glial isoform
of mammalian Neurofascin, we next wanted to test whethernfascb is expressed in myelinating glia in zebrafish. To do so,
we used fluorescence-activated cell sorting (FACS) to collect flu-
orescently labeled neurons and myelinating glia from transgenic
reporters (nbt:dsRed for neurons and mbp:nls-EGFP for myeli-
nating glia) for real-time PCR (STAR Methods). We found that
nfascb could be amplified from cDNA originating from the myeli-
nating glial cell population, but not the neuronal population (Fig-
ure 3A). Previous studies in mammals have shown that the
isoform of Neurofascin expressed bymyelinating glia is localized
to the tips of myelin sheaths at paranodal junctions. To test
whether Neurofascin B is similarly localized in zebrafish myeli-
nating oligodendroyctes, we generated a fluorescent fusion
protein (Neurofascin B-GFP), which we expressed in oligoden-
drocytes using sox10 and claudinK gene regulatory sequences
(STAR Methods). We observed that Neurofascin B-GFP does
indeed localize to the tips of myelin sheaths, further highlighting
the similarity of zebrafish Neurofascin B and the myelinating glialDevelopmental Cell 51, 1–15, December 16, 2019 3
Figure 2. Ultrastructural Analyses of the nfascbue56 Mutant Spinal Cord
(A andB) Transmission electronmicroscopy (TEM) images of sections through the spinal cord of wildtype (A) and nfascbue56mutants (B) at 5 dpf. Dorsal to the top,
midline left. Asterisks show myelinated cell bodies. Scale bars, 5 mm.
(C–D0) TEM images of cell bodies in wildtype (C andC0) and ue56mutants (D and D0) showing enwrapment of a cell body in themutant withmulti-lammellar myelin.
Scale bars, 1 mm.
(E–H) High magnification views of myelinated axons in the dorsal (E and F) and ventral (G and H) spinal cord of wildtype (E) and mutant (F) animals. Unmyelinated
axons with a diameter >0.3 mm highlighted in blue. Scale bars, 0.5 mm.
(I) Number of axons with a diameter > 0.3 mm in wildtype and nfascbue56mutants (wildtypemean 114.5 ± 23.71 SD, n = 6 animals, nfascbue56mutant mean 111.4 ±
23.69 SD, n = 7 animals, p = 0.8201, t test).
(J) Total number of myelinated axons in wildtype and nfascbue56mutants, and numbers in the dorsal and ventral domains of the spinal cord. (Total: wildtype mean
92.17 ± 19.57 SD and nfascbue56 mutant mean 53.57 ± 18.20 SD, p = 0.0036, t test. Dorsal: wildtype mean 36.17 ± 7.89 SD and nfascbue56 mutant mean 21.93 ±
8.60 SD, p = 0.0103, t test. Ventral: wildtype mean 56.00 ± 12.52 SD and nfascbue56 mutant mean 31.64 ± 11.81 SD, p = 0.0041, t test. All sets wildtype n = 6
animals and nfascbue56 mutant n = 7 animals).
(K) Average g-ratio per animal in wildtype and nfascbue56mutants at 5 dpf (wildtype mean 0.72 ± 0.01 SEM, n = 6 animals and nfascbue56mutant mean 0.73 ± 0.01
SEM, n = 7 animals, p = 0.7027, t test).
(L) G-ratios of all myelinated axons assessed in the dorsal spinal cord of wildtype (black) and nfascbue56 mutants (red) relative to axon caliber. Each point
represents a myelinated axon.
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cin B actually functions in oligodendrocytes to mediate normal
myelin targeting, we expressed the Neurofascin B-GFP fusion
protein in oligodendrocytes in nfascbue56 mutant animals. We
found that oligodendrocytes that expressed wildtype Neurofas-
cin B-GFP did not myelinate any cell bodies in either control
(n = 15) or nfascbue56 mutants (n = 13), indicating a rescue of4 Developmental Cell 51, 1–15, December 16, 2019the mutant phenotype (Figures 3C and 3D). These data indicate
that Neurofascin B is required by oligodendrocytes for correct
myelin targeting in the zebrafish CNS.
We next assessed whether myelinating glial Neurofascin is
required for myelin targeting in the mammalian CNS. To address
this, we generated mice that lacked Neurofascin in myelinating
glial cells. Mice in which Neurofascin is conditionally ablated in
Figure 3. Neurofascin Functions in Oligoden-
drocytes to Regulate Myelin Targeting
(A) Real-time PCR analyses of the expression of
nfascb, the myelin gene myrf, the neuronal genes
rbfox3a (NeuN) and caspr in neuronal (N) and mye-
linating glial (MG) cells separated using FACS.
(B) Confocal images of Nfascb-GFP with cells
counterlabelled with mRFP showing concentration
of NfascB-GFP at the tips of myelin sheaths (b1-3),
where paranodal junctions are localized. Scale bar,
5 mm (top panel) and 2.5 mm (b1-3).
(C and D) Confocal images of single oligodendro-
cytes expressing Nfascb-GFP in wild type (C) and
nfascbue56 mutants (D). Cells expressing wild type
NfascB-GFP never myelinate cell bodies, whether
they are mutant or wild type. Scale bars, 10 mm.
(E–G) Analysis of myelination in mice lacking Neu-
rofascin from oligodendrocytes.
(E and F) Confocal images of the dorsal horn where
assessments for myelination of cell bodies was
carried out in control (Nfasc+/+) and Neurofascin
mutants (Nfasc⁄/Nfasc186), showing MBP in
green, the neuronal marker NeuN in red, andDAPI to
indicate nuclei in blue. Insets show single neurons,
including an example of a myelinated cell body in
the mutant. Scale bar, 50 mm.
(G) Quantitation of myelinated cell body number in
controls and Nfasc⁄/Nfasc186 mutant mice (wild
type mean 0.29 ± 0.21 SD, 10 sections per mouse,
n = 5 mice, Nfasc⁄/Nfasc186 mean 6.51 ± 1.70
SD, 10 sections per mouse, n = 5 mice, p < 0.0001,
t test).
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postnatal day 15–16 (Pillai et al., 2009), an observation that we
confirmed (data not shown). Therefore, we generated mice
expressing Neurofascin 186, the major neuronal Neurofascin
isoform, but lacking the glial Neurofascin 155 isoform. After
backcrossing to a C57BL/6 background, this line was interbred
with Nfasc+/ mice to generate Nfasc⁄/Nfasc186 mice as pre-
viously described (Zonta et al., 2011). Although these mice
display ataxia, they are viable and have a normal life expectancy,
presumably due to the continuous production of Neurofascin
186 in neurons throughout life. We assessed whether
Nfasc⁄/Nfasc186 mice exhibited an increase in myelinated
cell bodies by examining a region of the dorsal horn of the spinal
cord where myelination of cell bodies has been detected in mu-
tants lacking Jam2 (Redmond et al., 2016). We analyzed mutant
mice at postnatal day 30 and observed a striking increase in the
myelination of cell bodies in Nfasc⁄/Nfasc186 mutants
compared to controls (Figures 3E–3G).
Together our data indicate that oligodendrocyte Neurofascin
is required to prevent myelin mistargeting to cell bodies in the
CNS of both zebrafish and mice.
Myelin Sheath Length Is Reduced in the Absence of
Oligodendrocyte Neurofascin
The fact that fewer large caliber axons are myelinated in
nfascbue56 mutants could simply be because oligodendrocytes
make so much myelin on cell bodies they do not have enough
to target to axons. Alternatively, Neurofascin B might play addi-tional roles in regulating the number and or length of sheaths pro-
duced by oligodendrocytes. To address this, we mosaically
labeledmyelinating oligodendrocytes in zebrafish to assess their
morphology (Figure 4; STAR Methods). We saw that individual
oligodendrocytes myelinated an average of about 3 cell bodies
in nfascbue56 mutants (Figures 4A–4E). Despite this, the number
of myelin sheaths made by individual oligodendrocytes on axons
was essentially normal (Figure 4F). These data, together with our
reporter and EM analyses, indicate that the targeting of myelin to
correct large caliber axons does not require nfascb, and that
Neurofascin B specifically prevents the mistargeting of myelin
to cell bodies in the CNS.
However, our analyses of oligodendrocyte morphology re-
vealed that myelin sheaths were 37% shorter in nfascbue56 mu-
tants, compared to controls (Figure 4G). Interestingly, myelin
sheaths were 35% shorter in the 9/29 nfascbue56 mutant oligo-
dendrocytes that did not myelinate cell bodies (Figure 4H),
indicating that Neurofascin B plays independent roles in myelin
targeting and regulation of sheath length. We found no evidence
of a role for Neurofascin B in regulating the growth of myelin
sheaths in the PNS (Figure S3). Similar to sheath targeting, we
found that expression of wildtype Neurofascin B-GFP in oligo-
dendrocytes rescued the reduction in myelin sheath length
observed in nfascbue56mutants (Figure 4I), indicating that sheath
length and targeting are regulated by oligodendrocyte Neurofas-
cin, and that a single neurofascin b gene product can ensure
both. We also observed an increase in cell body myelination
and a reduction in sheath length in nfascbue56/+ heterozygousDevelopmental Cell 51, 1–15, December 16, 2019 5
Figure 4. Oligodendrocyte Neurofascin Regulates Both Myelin Targeting and Sheath Length
(A–D) Confocal images of single oligodendrocytes labeled mosaically using mbp:mCherry-CAAX in wildtype (A), two nfascbue56 mutants (B and C), and a het-
erozygous nfascbue56/+ animal (D). Scale bars, 10mm.
(E–G) Number of myelinated cell bodies (E) and myelin sheaths (F) and the average length of myelin sheaths (G), made by individual oligodendrocytes in wildtype,
nfascbue56/+ hets, and nfascbue56 mutants.
(E) Myelination of cell bodies is increased in both nfascbue56/+ and nfascbue56 mutant oligodendrocytes (wildtype median 0.0, 25th percentile = 0.0, 75th
percentile = 0.4, n = 28, nfascbue56/+median 1.0, 25th percentile = 0, 75th percentile = 2.0, n = 32, nfascbue56median 3.0, 25th percentile = 1.1, 75th percentile = 4.4,
n = 24; wildtype versus nfascbue56/+ p = 0.0056, wildtype versus nfascbue56 p < 0.0001, nfascbue56/+ versus nfascbue56 p = 0.0002, all Mann–Whitney test).
(F) Number of myelin sheaths per oligodendrocyte is similar in wildtype, nfascbue56/+ and nfascbue56 (wildtype mean 12.28 ± 4.27 SD, n = 28, nfascbue56/+ mean
12.23 ± 3.79 SD, n = 30, nfascbue56 mean 12.56 ± 3.78 SD, n = 24; wildtype versus nfascbue56/+. ANOVA = 0.948).
(legend continued on next page)
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distinct aspects of CNS myelination in a dose-dependent
manner.
To test whether the role ofmyelinating oligodendrocyte Neuro-
fascin in regulating sheath length was conserved in mammals,
we analyzed internodal distance in mutant mice. To do so, we
teased myelinated axons from the ventral spinal cord at post-
natal day 30, which revealed a 40% reduction in sheath length
(Figures 4J–4L), very similar in extent to that observed in
zebrafish, indicating that the role of Neurofascin in controlling
myelin sheath length, as well as in regulating myelin targeting,
is conserved across vertebrates.
Neurofascin Independently Regulates the Dynamics of
Myelin Targeting and Sheath Growth by Individual
Oligodendrocytes
Our data show that disruption to oligodendrocyte Neurofascin
impairs bothmyelin targeting and sheath length. To better under-
stand the temporal relationship between targeting and sheath
growth, we time-lapse imaged myelination by individual oligo-
dendrocytes in wildtype controls. We imaged membrane-teth-
ered GFP-expressing oligodendrocytes at 2.5 min intervals for
16 h each, starting prior to sheath formation (STAR Methods).
We have previously shown that individual oligodendrocytes
initiate formation of essentially all of their myelin sheaths on
axons within a critical period of 4–6 h (Czopka et al., 2013).
Here we wanted to define how the formation of sheaths relates
to sheath growth. In all of the oligodendrocytes examined, we
observed that during the critical period of sheath formation,
distinct cellular processes could engage in entirely different ac-
tivities at the same time: distinct processes could be forming a
new sheath, supporting slow or fast sheath growth along an
axon, retracting an exploratory process, or retracting a sheath
from a cell body or axon (Figure 5A; Video S1). The fact that these
distinct activities can occur at the same time indicates that the
mechanisms that control myelin targeting and sheath growth
are controlled by distinct localized interactions.
We next wanted to compare the dynamics of myelin targeting
and sheath growth between wildtype and Neurofascin
B-depleted animals. We first used the nfascb-MO, which
phenocopied the nfascbue56 mutant, because it was not
possible to phenotypically identify nfascbue56 mutants at the
start of time-lapsing myelination at 2.5 dpf. We imaged 15 con-
trol-injected and 30 nfascb MO-injected Tg(sox10:KalTA4,
UAS:mEGFP) animals for 15 h at 10 min intervals. We first
observed that both the number of sheaths formed and the dura-
tion of the critical period of sheath formation were similar in(G) Average sheath length per oligodendrocyte in wildtype, nfascbue56/+, and nfa
25.75 ± 1.12 SEM, n = 30, nfascbue56mean 19.46 ± 1.31 SEM, n = 24; wildtype ver
versus nfascbue56 p = 0.0005, all t tests).
(H) Average sheath length per oligodendrocyte in wildtype andmutant oligodendro
nfascbue56 mean 21.07 ± 1.54 SEM, n = 9; p < 0.0001, Mann–Whitney test).
(I) Average sheath length per oligodendrocyte in nfascbue56 mutants and wildtype
length (wildtype + nfascb-GFP mean 31.58 ± 1.41 SEM, n = 15, nfascbue56 + nfa
(E–I) n in all cases refers to animals.
(J and K) Confocal images of teased fiber preparations taken from wild type (K) an
Neurofascin 186 (green) and neurofilament 200 (red). Scale bars, 25 mm.
(L) Quantitation of myelin sheath length inNeurofascinmutant mice. Lack of Nfasc
6.88 SEM, n = 5 mice, Nfasc⁄/Nfasc186 mean 202.1 ± 17.94 SEM, n = 5; 50 incontrol and Neurofascin B-depleted animals (Figures 5B, 5C,
5F, and 5G; Videos S2 and S3), underscoring our observations
of normal myelin targeting to axons in nfascbue56 animals. We
next asked when the mistargeting of myelin to cell bodies
occurred: was it during the critical period of sheath formation,
or later? We found that when oligodendrocytes myelinated cell
bodies in nfascbmorphants they did so during the critical period
of sheath formation, concomitant with the formation of sheaths
on axons (Figures 5C and 5H; Video S3). We observed that
almost all cases of cell bodymyelination occur by transformation
of an exploratory process into a sheet-like protrusion that
directly enwraps the cell body (Figure 5D; Video S4). In contrast,
exploratory processes that associate with cell bodies in controls
almost always subsequently retract from the cell body (Figure 5E;
Video S5). In the absence of Neurofascin B, it is possible that ol-
igodendrocytes are simply incapable of retracting myelinating
processes from a target. However, the rate of sheath retraction
from axons was unaffected in nfascbmorphants (Figure 5I), indi-
cating that nfascb-deficient oligodendrocytes retain the capacity
to withdraw processes from targets.
We next wanted to understand the reduction in sheath length
in nfascb-disrupted animals. We first assessed the initial appear-
ance of myelin sheaths made on axons. We found that immedi-
ately upon their formation, myelin sheaths were on average 4 mm
in length in both wildtype and nfascb MO-injected animals (Fig-
ures 6A and 6B), further indicating that the initial formation of
myelin sheaths is independent of Neurofascin B.We next wanted
to determine whether Neurofascin B is required to ensure normal
myelin sheath growth during a specific phase of sheath elonga-
tion, continuously during elongation, or simply to maintain stable
myelin sheaths once elongated. We first plotted the rate of
sheath elongation relative to the time of their formation by an in-
dividual oligodendrocyte. We saw that sheaths grew at similar
speeds whether they were the first or last made by an oligoden-
drocyte. Although the speed of sheath growth is variable (Figures
6D and 6F), the average speed of growth is reduced in nfascb-
morphants from soon after their formation (Figures 6C–6F;
Videos S6 and S7), a phenotype that becomesmore pronounced
over time (Figures 6G and 6H).We found that this reduction in the
average speed of sheath growth reflects a reduction in the speed
of positive elongation, an increase in the number of sheaths that
fail to elongate and an increase in those that shrink over time
(Figure 6H; Video S8). These results suggest that nfascb is
required to support the normal growth of myelin sheaths along
axons soon after their formation. To corroborate our findings in
nfascb-morphants and examine myelination at a slightly later
stage, we time-lapse imaged Tg(mbp:EGFP-CAAX) wildtypesscbue56 mutants (wildtype mean 30.97 ± 1.50 SEM, n = 28, nfascbue56/+ mean
sus nfascbue56/+ p = 0.0085, wildtype versus nfascbue56 p < 0.0001, nfascbue56/+
cytes with no myelinated cell bodies (wildtype mean 32.11 ± 1.50 SEM, n = 20,
siblings injected with wildtype nfascb-GFP, which rescues the defect in sheath
scb-GFP, mean 31.66 ± 1.80 SEM, n = 13, p = 0.9726, t test).
d Neurofascinmutant (J) mice, stained with antibodies that detect Kv1.1 (red),
155 results in a 40% reduction in internode lengths. Wildtypemean 338.4 mm±
ternodes per mouse, p = 0.0001, t test.
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of cell bodies in mutants (Figure 6L; Video S11), that the speed
of myelin sheath growth along axons remained reduced, and
that a large proportion of myelin sheaths shrank over time in
nfascbue56 mutants (Figures 6I–6K; Videos S9 and S10).
Together our data indicate that oligodendrocyte Neurofascin
mediates two distinct roles during myelination: (1) preventing
the myelination of cell bodies, and (2) promoting the stable elon-
gation of sheaths along axons.
Caspr Regulates Sheath Elongation but Not Myelin
Targeting
The fact that oligodendrocyte Neurofascin prevents myelination
of cell bodies and promotes the growth of sheaths along axons
begs the question as to what drives these distinct aspects of
myelination. One possibility is that interactions with different
molecules on neuronal cell bodies versus axons regulate the
outcome. Along the axon, it is well established that myelinating
glial Neurofascin 155 interacts with the cell adhesion molecules
Caspr and Contactin 1 (Bhat et al., 2001; Boyle et al., 2001; Ço-
lakoglu et al., 2014). Although previous studies have indicated
that disruption to Contactin 1 leads to severe disruption to
axonal growth and myelination in the CNS (Çolakoglu et al.,
2014), loss of Caspr function may more specifically dysregulate
axon-glial adhesion (Brivio et al., 2017).
Therefore, we sought to test whether Caspr might also regu-
late myelin targeting and growth. We first analyzed myelination
in a zebrafish mutant generated through the zebrafish mutation
project (Kettleborough et al., 2013), in which a T to A mutation
(sa12772) induces a STOP codon at amino acid 200 of 1,310 of
Caspr (STAR Methods). Similar to nfascbue56 mutants, the num-
ber of myelin sheaths made by individual oligodendrocytes was
unaffected in casprsa12772mutants, indicating no requirement for
Caspr in targeting myelin to axons in the CNS (Figures 7A, 7B,
and 7D). Although we did observe amodest increase in the num-
ber of myelinated cell bodies made by individual oligodendro-
cytes in casprsa12772 mutants (Figure 7C), this was 10-fold lower
in magnitude to the phenotype observed in nfascbue56 mutants
(Compare median myelinated cell number per OL in Figures 4E
and 7C). Further arguing against a specific role for Caspr in
myelin targeting, we observed no evidence of myelinFigure 5. Neurofascin B Regulates Myelin Targeting during the Critica
(A–A0 0 0) Single time-point images of an individual oligodendrocyte in a wild-type an
time: 1=sheath formation, 2=slow sheath growth, 3=rapid sheath growth, 4=explo
cell body, 7=retraction from an axon. Scale bar, 10 mm.
(B and B0) Single time-point confocal images of an individual oligodendrocyte in a
the end (A0) of the critical period. Scale bar, 10 mm.
(C and C0 ) Single time-point confocal images of an individual oligodendrocyte in a
and toward the end (A0) of the critical period. Note that a cell body has become
(D–D0 0 0) Time series showing myelination of a cell body in a nfascb MO-injected
(E–E0 0 0) Time series showing a myelinating process being retracted from a cell bo
(F) Number of myelin sheaths generated on axons per oligodendrocyte during t
13.50 ± 2.91 SD, n = 20 oligodendrocytes from 13 animals, nfascb MO mean 12
(G) Graph showing the duration between the first formed and the last formed my
animals (control mean 3.55 ± 1.45 SD, n = 13 oligodendrocytes from 10 animals
p = 0.4249, t test).
(H) Time of cell body myelination during time-lapse of control (none were myeli
B-depleted cells during the same period as axons.
(I) Number of myelin sheaths retracted from axons per oligodendrocyte during tim
SD, n = 16 oligodendrocytes from 13 animals, nfascb MO mean 2.81 ± 1.27 SD,mistargeting to cell bodies in Caspr mutant mice (Figures 7F–
7H), which we analyzed at postnatal day 23 in the same region
of the dorsal spinal cord in which we observed myelin mistarget-
ing to cell bodies in Neurofascin mutant mice. Together our data
from both zebrafish andmice indicate that Caspr does not play a
major role in regulating myelin targeting in the CNS. This sug-
gests that Neurofascin mediates its role in preventing myelin tar-
geting to cell bodies in a Caspr-independent manner, the basis
of which remains to be determined.
Our analyses of myelination by individual oligodendrocytes,
did however, indicate a very clear reduction in myelin sheath
length in zebrafish casprsa12772 mutants (Figure 7E). Similarly,
analysis of internodal length in Caspr mutant mice teased nerves
also exhibited a reduction in sheath length (Figures 7I–7K), indi-
cating conservation in Caspr function between zebrafish and
mice, as we observed for oligodendrocyte Neurofascin. To test
to what extent Caspr deficiency phenocopied the defects in
sheath elongation and stability observed in nfascb-deficient an-
imals, we carried out time-lapse imaging of myelination in
casprsa12772 mutant zebrafish. As observed in nfascbmorphants
and mutants, the speed of sheath elongation was significantly
reduced in casprsa12772 mutants (Figures 7L–7N), and the pro-
portion of myelin sheaths that shrank over time increased (Fig-
ure 7N). Together these data indicate that Caspr supports myelin
sheath elongation along axons in a similar manner to Neurofas-
cin B, likely due to their association in an adhesion complex at
the axon-glial interface.
DISCUSSION
To identify mechanisms of myelination we carried out a genetic
screen in zebrafish, which, together with analyses in mice, iden-
tified roles for oligodendrocyte Neurofascin in preventing the
mistargeting of myelin to cell bodies and supporting the growth
of myelin sheaths, and for Caspr in promoting sheath growth .
Our time-lapse analysis showed that the distinct myelinating
processes of single oligodendrocytes can engage in myelin tar-
geting and growth at the same time and that Neurofascin medi-
ates its roles in myelination independently of one another. Oligo-
dendrocytes can myelinate cell body shaped plastic beads
(Redmond et al., 2016) and generate myelin sheaths alongl Period of Sheath Formation and Retraction
imal as itsmyelinating processes exhibit several distinct dynamic activities over
ratory process retraction, 5=engagement with a cell body, 6=retraction from a
wildtype animal as it is forming myelin sheaths at the beginning (A) and toward
nfascbMO-injected animal as it is forming myelin sheaths at the beginning (A)
myelinated during this time (arrows). Scale bar, 10 mm.
animal. Scale bar, 10 mm.
dy in a control. Scale bar, 10 mm.
ime-lapse analyses of control and nfascb MO-injected animals (control mean
.35 ± 3.30 SD, n = 34 oligodendrocytes from 17 animals, p = 0.2041, t test).
elin sheath by individual oligodendrocytes in control and nfascb MO-injected
, nfascb MO mean 4.11 ± 2.30 SD, n = 29 oligodendrocytes from 21 animals,
nated) and nfascb MO-injected animals. Cell bodies are myelinated by Nfasc
e-lapse of control and nfascb MO-injected animals (control mean 2.81 ± 1.60
n = 26 oligodendrocytes from 17 animals, p = 0.7463, Mann–Whitney test).
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Figure 6. Neurofascin B Regulates Myelin Sheath Elongation and Stability
(A and A0) Single time-point confocal images of a myelinating process in a Tg(sox10KalTA4, UAS mEGFP) control that makes contact with a target axon (A) and
transitions into a recognizable myelin sheath (A0). Scale bar, 5 mm.
(legend continued on next page)
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tion taking place in the absence of specific molecular interac-
tions of myelinating processes and their targets. Myelination in
the absence of oligodendrocyte Neurofascin may resemble
such default myelination, with stochastic targeting of myelin to
biophysically permissive substrates and unstable sheath growth
along axons. Therefore, Neurofascin-dependent interactions be-
tween myelinating processes and targets represent key media-
tors of myelin targeting and growth in vivo. We now need to
ask: how can Neurofascin mediate such distinct aspects of mye-
lination within the same cell at the same time?
At present, it is unclear how oligodendrocyte Neurofascin pre-
vents myelination of cell bodies. Our time-lapse analyses indi-
cate that Neurofascinmutant oligodendrocytes retain the capac-
ity to retract myelinating processes from axons during
myelination. Therefore, the simplest model is that a signal local-
ized to cell bodies interacts with Neurofascin onmyelinating pro-
cesses and triggers retraction from the cell body. The junctional
adhesion molecule Jam2 is an inhibitory signal that can prevent
myelination of cell bodies (Redmond et al., 2016). Although inter-
action between neuronal Jam2 and oligodendrocyte Neurofas-
cin cannot be ruled out, the extracellular domains of junctional
adhesionmolecules primarily bind other JAMmolecules or integ-
rins (Bazzoni, 2003), and the myelination of cell bodies in Jam2
mutants is restricted to a specific neuronal subtype (Redmond
et al., 2016), unlike the broadmyelination of cell bodies observed
in Neurofascin mutants. To date, the key known binding partners
of oligodendrocyte Neurofascin155 are Caspr and Contactin 1.
Our study indicates that Caspr does not play a prominent role
in preventing myelin targeting to cell bodies. Although Caspr
and Contactin 1 are co-dependent at the paranodal junction, it
remains possible that Contactin 1 could serve as an inhibitory
cue that prevents myelination of cell bodies. There is evidence
that Caspr can prevent direct binding of Contactin 1 to Neurofas-
cin 155 (Gollan et al., 2003), and Caspr is not normally localized
to neuronal cell bodies (Boyle et al., 2001; Redmond et al., 2016).(B) Average length of myelin sheaths immediately upon formation in control and
percentile 4.93, n = 91 from 13 animals and nfascb MO median = 3.67, 25th perc
Mann–Whitney test.
(C andC0 ) Confocal images of amyelin sheath elongating over time during the perio
of myelin sheaths. Scale bar, 5 mm.
(D) Average speed of individual sheath elongation in controls over a 12-h period
represents a single sheath, imaged across 13 animals. No significant difference
Wallis test.
(E and E0) Single time-point confocal images of amyelin sheath elongating over tim
Scale bar, 5 mm.
(F) Average speed of sheath elongation in nfascbMO-injected animal over a 12-h
point represents a single sheath, imaged across 21 animals. No significant differe
Wallis test.
(G and G0) Single time-point confocal images of a myelin sheath shrinking over t
(H) Speed of elongation of individual myelin sheaths in control and nfascbMO-inje
n = 34 sheaths in 8 animals, nfascb MO n = 66 sheaths in 13 animals: 0–6 h: con
Mann–Whitney-test. 6–12 h: control mean speed 0.89 ± 0.42 SD, nfascb MO me
sheaths shrinking in nfascb MO-injected animals between 6–12 h after sheath fo
(I and I0) Confocal images of a myelin sheath elongating in a wildtype animal. Sc
(J and J0) Confocal images of a myelin sheath elongating in an nfascbue56 mutan
(K) Speed of myelin sheath elongation in Tg(mbp:EGFP-CAAX) wildtype and nfa
nfascbue56 mutant mean 0.06 ± 0.23 SD, n = 215 from 9 animals, p < 0.0001, Man
myelin sheaths.
(L) Cell body myelination in nfascbue56 mutants. Scale bar, 10 mm.Therefore, a Caspr-independent direct binding of Contactin 1 to
Neurofascin could inhibit myelination of cell bodies. Testing this
will require extensive cell-type specific loss and gain of Contac-
tin 1 function approaches, because Contactin 1 mutant mice
exhibit relatively severe disruption to both axonal development
and myelination (Çolakoglu et al., 2014). In addition, other un-
known factors might bind to or regulate oligodendrocyte
Neurofascin. Neurofascin 155 is subject to post-translational
modification, including cleavage by metalloproteases (Maier
et al., 2006), indicating that its context dependent processing
might contribute to its distinct roles.
Insight into how Neurofascin might affect sheath growth
comes from analyses of its role at the axon-glial paranodal junc-
tion. Mutant mice with complete loss of either Neurofascin
(Zonta et al., 2008) or Caspr (Brivio et al., 2017) have longer
gaps between adjacent myelin sheaths at nodes of Ranvier.
However, expression of Neurofascin 155 in myelinating glia or
Caspr in neurons is sufficient to restore formation of the parano-
dal complex and to rescue the increase in nodal gap length in
each respective mutant. Our observations of reduced sheath
length in both neurofascin and caspr mutant fish and mice sug-
gest that the longer nodal gaps seen in corresponding mutants
might reflect slower myelin sheath elongation. However, the
rescue of nodal gap length brought about by expression of Neu-
rofascin 155 in myelinating glia does not require its intracellular
domain (Zonta et al., 2008). In contrast, closing of the nodal
gap does require the intracellular domain of Caspr (Brivio et al.,
2017). These data indicate that closing of the gap mediated by
the axon-glial adhesion complex is driven by the axon and not
by the myelinating process. Testing whether myelin sheath
growth might also be driven by a Caspr-Neurofascin interaction
in an inside-out, axon to myelin, manner would require extensive
investigations of sheath growth in animals with specific disrup-
tion to the intracellular signaling of oligodendrocyte Neurofascin
and neuronal Caspr. Alternatively, the deficits we observe in
myelin sheath length in Neurofascin and Caspr mutants maynfascb MO-injected animals. Control median = 4.02, 25th percentile 3.45, 75th
entile 3.10, 75th percentile 4.63, n = 195 sheaths from 21 animals, p = 0.0611,
d of sheath formation in a control animal. Arrowheads in all panels denote ends
, starting from the hour of their formation during the critical period. Each point
in speed of growth based on time of sheath formation, p = 0.8933, Kruskal-
e during the critical period of sheath formation in an nfascbMO-injected animal.
period, starting from the hour of their formation during the critical period. Each
nce in speed of growth based on time of sheath formation, p = 0.6301, Kruskal–
ime after the critical period in a nfascb MO-injected animal. Scale bar, 5 mm.
cted animals for the first 6 h after their formation and the following 6 h. (control
trol mean speed 0.77 ± 0.40 SD, nfascb MO mean 0.56 ± 0.41 SD, p = 0.0133,
an 0.185 ± 0.60 SD, p < 0.0001, Mann–Whitney test. Note the large number of
rmation.
ale bar, 10 mm.
t. Scale bar, 10 mm.
scb
ue56
mutants (control mean speed 0.34 ± 0.40 SD, n = 118 from 6 animals,
n–Whitney test. 16.1% in controls and 36.4% in nfascbue56 represent shrinking
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Figure 7. Caspr Regulates Myelin Sheath Elongation and Stability, but Not Targeting
(A and B) Confocal images of single oligodendrocytes labeled mosaically using mbp:mCherry-CAAX in wildtype (A) and casprsa12772 mutants at 5 dpf. Scale
bar, 10 mm.
(legend continued on next page)
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ports sheath growth. Indeed, dysregulation of axon-myelin
adhesion has recently been shown to impair myelination in the
CNS (Elazar et al., 2019b).
In summary, oligodendrocyte Neurofascin regulates both
myelin targeting and growth at the same time in individual cells.
The functional consequences of cell body myelination and
impaired growth need to be disentangled, which will require
in depth investigation and comparison of mutants with disrup-
tion to oligodendrocyte and neuronal Caspr. This will be impor-
tant, not only to understand fundamental mechanisms, but also
to gain insight into the increasing number of human diseases in
which disruption to oligodendrocyte Neurofascin or axonal
Caspr are evident (Efthymiou et al., 2019; Hinman et al.,
2006; Howell et al., 2006; Low et al., 2018; Smigiel et al.,
2018). The mechanistic dissection of how oligodendrocyte
Neurofascin, as a single cell adhesion molecule, can regulate
two distinct and essential aspects of myelination in the same
cell at the same time also represents an important challenge
for the future.
STAR+METHODS
Detailed methods are provided in the online version of this paper
and include the following:
d KEY RESOURCES TABLE
d LEAD CONTACT AND MATERIALS AVAILABILITY
























B The Following Existing Mutant and Transgenic Lines
Were Used
B ENU Mutagenesis and Screen
B Mapping-By-Sequencing
B Mouse Lines
d METHOD DETAILSE) Number of myelinated cell bodies (C), number of myelin sheaths (D), and the
, and casprsa12772 mutants.
Myelination of cell bodies is increased slightly in casprsa12772 mutant oligode
mals; casprsa12772/+median 0.0, 25th percentile 0.0, 75th percentile 0.0, n = 35, c
type versus casprsa12772/+ p = 0.8056, wildtype versus casprsa12772 p = 0.030
Number of myelin sheaths per oligodendrocytes is similar in wildtype, casp
prsa12772/+ mean 11.19 ± 3.26 SD, n = 33 animals, casprsa12772 mean 12.00 ±
Myelin sheath length is reduced in casprsa12772 mutants (wildtype mean 29.1
prsa12772 mean 23.55 ± 1.30 SEM, n = 24 animals; wildtype versus casprsa127
prsa12772 p = 0.0374, all t test).
nd G) Confocal images of the dorsal horn of the spinal cord in wildtype (F) and
elinated cell bodies were searched for. Scale bar, 50 mm.
and G0) Higher magnification views of regions within the dorsal horn of wild t
elin basic protein (green), NeuN (red), and DAPI (blue). Scale bar, 5 mm.
Graph showing that essentially no myelinated cell bodies were observed in wil
tions per mouse), Caspr⁄ 0.257 ± 0.083 SEM, n = 5 (10 sections per mouse
nd J) Confocal images of teased fiber preparations taken from wild type (I)
rofascin 186 (green), and neurofilament 200 (red). Scale bars, 25 mm.
Quantitation of myelin sheath length in Caspr mutant mice. Caspr internode le
5, Caspr 226.5 ± 8.96 SEM, n = 5 animals, 50 internodes per mouse, p < 0.0
nd L00) Confocal images of a myelin sheath elongating in a wildtype Tg(mbp:E
and M0) Confocal images of a myelin sheath elongating in a casprsa12772 muta
Speed of myelin sheath elongation in wildtype and casprsa12772 mutants: wild
6 ± 0.31 SD, n = 151 sheaths from 7 animals, p < 0.0001, Mann–Whitney test.B Cloning of Nfascb cDNA
B Rescue of the nfascbue56 Mutant Phenotype
B Morpholino Experiments
B Genotyping
B Generation of UAS:nfascb-EGFP-pA
B Generation of nfascB-EGFP-UAS-mCherry
B RT-PCR
B FACS and RT-PCR
B Transmission Electron Microscopy
B Single Cell Labeling
B Transgenic Cell-Type Specific Rescue
B Live Imaging
B Image Processing and Analysis
B Mouse Tissue Preparation and Immunohistochemistry
B Mouse Spinal Cord Image Acquisition and Analysis
d QUANTIFICATION AND STATISTICAL ANALYSES
d DATA AND CODE AVAILABILITY
SUPPLEMENTAL INFORMATION
Supplemental Information can be found online at https://doi.org/10.1016/j.
devcel.2019.10.016.
ACKNOWLEDGMENTS
We thank members of the Lyons lab for feedback and the University of Edin-
burgh zebrafish and electron microscopy facilities for expert assistance.
This work was supported by theWellcome Trust, United Kingdom, through Se-
nior Research Fellowships (102836/Z/13/Z and 214244/Z/18/Z), to D.A.L, a
Wellcome Trust Investigator Award (107008) to P.J.B., as well as a Wellcome
Trust Research Career Development Fellowship (095722/Z/11/Z) and a Well-
come Senior Fellowship (207483/Z/17/Z) to RJP, and also by the MS Society,
United Kingdom, through a research grant (697), and by the Lister Institute,
United Kingdom, through a research prize to D.A.L.
AUTHOR CONTRIBUTIONS
Conceptualization, A.K., P.J.B., and D.A.L.; Investigation, A.K., A.-M.R., L.K.,
D.L.S., M.R.-B., R.G.A., S.K., and S.K.B.-K.; Formal Analysis, R.J.P.; Writing –length of myelin sheaths (D), made by individual oligodendrocytes in wildtype,
ndrocytes (wildtype median 0.0, 25th percentile 0.0, 75th percentile 0.0, n = 15
asprsa12772median 0.25, 25th percentile 0.0, 75th percentile 1.5 , n = 25 animals;
5, casprsa12772/+ versus casprsa12772 p = 0.0156, all Mann–Whitney test.
rsa12772/+ and casprsa12772 (wildtype mean 11.78 ± 5.14 SD, n = 15 animals,
3.54 SD, n = 24; ANOVA = 0.712).
4 ± 1.71 SEM, n = 15, casprsa12772/+ mean 27.58 ± 1.31 SEM, n = 33 animals,
72/+ p = 0.4954, wildtype versus casprsa12772 p = 0.0124, casprsa12772/+ versus
Caspr mutant (G) mice, indicating the region indicated by dashed lines wherein
ype (F0) and Caspr mutant (G0) animals stained with antibodies that recognize
d type or Casprmutant animals. Wild type mean 0.2800 ± 0.049 SEM, n = 5 (10
), p = 0.8147, t test.
and Caspr mutant (J) mice, stained with antibodies that detect Kv1.1 (red),
ngths are reduced compared to wild type; wild type mean 310.7 ± 5.32 SEM,
001, t test.
GFP-CAAX) animal. Scale bar, 10 mm.
nt. Scale bar, 10 mm.
type mean 0.36 ± 0.35 SD, n = 122 sheaths from 6 animals, casprsa12772 mean
14.8% in controls and 28.5% in nfascbue56 represent shrinking myelin sheaths.
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Antibodies
Mouse Anti-NeuN IgG1 Clone A60, 1:500 Millipore Cat#MAB377, RRID:AB_2298772
Mouse Anti-Caspr IgM, 1:50 Dr. Matthew Rasband N/A
Mouse Anti-NF200, 1:20000 Sigma Cat#N0142, RRID:AB_477257
Mouse Anti- Kv 1.1 IgG2b, 1:200 Neuromab Cat#75–105, RRID:AB_2128566
Rabbit Anti-MBP Pep-7, 1:1000 Dr. Peter Brophy N/A
Rabbit Anti-MNF2 (Anti-Nfasc186), 1:1000 Dr. Peter Brophy N/A
Goat Anti-Mouse AlexaFlour 488, 1:1000 Thermofisher Cat#A-21141, RRID:AB_2535778
Goat Anti-Mouse AlexaFlour 594, 1:1000 Thermofisher Cat#A-21125, RRID:AB_2535767
Goat Anti-Mouse AlexaFlour 647, 1:1000 Thermofisher Cat#A-21240, RRID:AB_2535809
Goat Anti-Mouse FITC, 1:100 Southern Biotec Cat# 1021-02, RRID:AB_2794237
Goat Anti-Rabbit AlexaFlour 488, 1:1000 Molecular Probes Cat# A-11008, RRID:AB_143165
Donkey Anti-Rabbit AlexaFlour 594, 1:1000 Jackson ImmunoResearch Cat#111-585-14,RRID:AB_2307325
Experimental Models: Organisms/Strains
Zebrafish: Tg(mbp:EGFP-CAAX) (Almeida et al., 2011) ZFIN: ZDB-ALT-120103-2
Zebrafish: Tg(mbp:nlsEGFP) (Karttunen et al., 2017)
Zebrafish: Tg(NBT:DsRed, Synon.
Tg(Xla.Tubb:DsRed), zf148Tg
(Peri and N€usslein-Volhard, 2008) ZDB-ALT-081027-2
Tg(cntn1b:mCherry) (Czopka et al., 2013) ZDB-TGCONSTRUCT-140610-5
Zebrafish: Tg(sox10:KalTA4) (Almeida and Lyons, 2015) N/A
Tg(cldnk:Gal4) (M€unzel et al., 2012) ZDB-TGCONSTRUCT-120207-1
Zebrafish: Tg(UAS:Mem-GFP) (Kwan et al., 2007) N/A




Mouse: Nfasc-/-/Nfasc186 (Zonta et al., 2011) N/A
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Tol2 Kit (Kwan et al., 2007) http://tol2kit.genetics.utah.edu/
index.php/ Main_Page
Software and Algorithms
Zen, Zen Blue Zeiss RRID:SCR_013672
Fiji (Schindelin et al., 2012) RRID:SCR_002285
GraphPad Prism GraphPad software RRID:SCR_015807
Adobe Photoshop Adobe RRID:SCR_014199
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Lyons (david.lyons@ed.ac.uk).
EXPERIMENTAL MODEL AND SUBJECT DETAILS
Zebrafish Lines
All zebrafish were maintained under standard conditions in the Queen’s Medical Research Institute CBS Aquatics facility at the Uni-
versity of Edinburgh. All mouse work conformed to UK legislation (Scientific Procedures Act of 1986), and to University of Edinburgh
Ethical Review Committee policy. Studies were carried out with approval from the UK Home Office and according to its regulations,
under project licenses 60/8436 and 70/8436. Adult animals were kept in a 14 hours light and 10 hours dark cycle. Embryos were kept
at 28.5C in 10mM HEPES-buffered E3 Embryo medium or conditioned aquarium water with methylene blue.
Throughout the text and in figures, ‘Tg’ denotes a stable, germline inserted transgenic line.
The Following Existing Mutant and Transgenic Lines Were Used
Tg(mbp:EGFP-CAAX) (Almeida et al., 2011) Tg(mbp:nlsEGFP) (Karttunen et al., 2017) Tg(Xla.Tubb:DsRed) referred to as
Tg(NBT:DsRed) (Peri and N€usslein-Volhard, 2008); Tg(sox10:KaltA4)(Almeida and Lyons, 2015), Tg(UAS:mem-GFP) (Kwan et al.,
2007), casprsa12772(Kettleborough et al., 2013): note the caspr gene is also referred to as cntnap1 or caspr1. The nfascbue56 mutant
was identified in the genetic screen described in this manuscript.Developmental Cell 51, 1–15.e1–e6, December 16, 2019 e2
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10 adult AB males were mutagenized with 3.5mM ENU for 1 hr per week over three consecutive weeks. Assessment of mutagenesis
efficiency wasmade by crossing with carriers of a mutation, sox10cls (Kelsh et al., 1996), which disrupts pigment formation. Well-mu-
tagenised males were crossed with AB females to generate the F1 generation. F1 individuals were bred with Tg(mbp:GFP-CAAX)
animals to introduce the myelin reporter into the mutagenized stocks and generate individual F2 families. We generated 212 F2 fam-
ilies, and screened 946 clutches from these families for disruption to mbp:EGFP-CAAX expression at 5 dpf. See Kegel et al. (2019)
Kegel et al., 2019 for extensive details onmutagenesis protocol, assessment of mutagenesis efficiency and breeding scheme prior to
screen.
Mapping-By-Sequencing
Following an outcross to WIK, pooled DNA from 100 mutant recombinants and pooled DNA from 150 sibling recombinants was
sequenced separately on an Illumina HiSeq4000 (Edinburgh Genomics) to a coverage of 18X. We processed this data through a
slightly modified version of the Variant Discovery Mapping (VDM) CloudMap pipeline (Minevich et al., 2012), on an in-house Galaxy
server using the Zv9/danRer7 genome and annotation. For both the VDM plots and assessing the list of candidate variants we sub-
tracted a list of wildtype variants compiled from sequencing of the ekwill strain plus previously published data (Butler et al., 2015;
LaFave et al., 2014; Obholzer et al., 2012). From the prospective candidate mutations in the region of chromosome 23 linked to
the mutant phenotype, we filtered for prospective nonsense mutations likely to result in strong loss of function of encoded proteins.
The candidate list was further filtered by excluding polymorphisms found in other mutants that we sequenced that derived from the
same ENU screen. We designed genotyping assays to test candidate STOP codon-inducing mutation linked to the ue56 mutant
phenotype. We identified a base change (C >T) at position 3034 in the neurofascin b coding sequence that was present in all
ue56 sequence reads, and which was predicted to result in a STOP mutation at aa position 1015 of the neurofascin B protein.
Mouse Lines
All mouse work conformed to UK legislation (Scientific Procedures Act of 1986), and to University of Edinburgh Ethical Review Com-
mittee policy. The generation of Nfasc-/- mice and Caspr-/- mice has been previously described (Gollan et al., 2003; Sherman et al.,
2005). Transgenic mice expressing Nfasc186 with a C-terminal FLAG tag sequence under the control of the Thy1.2 promoter has
been described (Zonta et al., 2011) and are referred to here as Nfasc186. These mice were interbred with Nfasc+/- to generate
Nfasc-/-/Nfasc186 mice. All mice were backcrossed to a C57BL/6 background for at least 10 generations.
METHOD DETAILS
Cloning of Nfascb cDNA
To clone wildtype nfascb cDNA we carried out PCR with high-fidelity DNA polymerase Phusion (Neb) from a pool of wildtype zebra-
fish total cDNA (reverse-transcribed from total mRNA extracted from AB 5dpf zebrafish). We used forward primer 50-ACAAAATTA
CACCAAAACGCTGT-30 (which binds 6 bp upstream of the predicted start codon) and reverse primer 50-AGCCAGTCTGACAGAT
TAAATGGA-30 (which binds 45bp downstream of the predicted stop codon), designed based on NCBI transcript XM_005162102
(note that the forward primer anneals to a region currently predicted to be intronic, but previously annotated as an exon). This
PCR amplified a 3750 bp cDNA product, which we purified and TOPO-cloned (using the zero Blunt TOPO PCR Cloning Kit,
Thermo Fisher Scientific,450245) to generate pCRII-nfascb. We sequenced four pCRII-nfascb clones and in all we identified a com-
plete nfascbORF of 3501 bp that matched that of nfascb predicted transcript variant31mRNA annotated in NCBI (XM_005162102).
The sequence was submitted and published in GenBank at ncbi.nlm.nih.gov with the accession number GenBank: MK070493.
Rescue of the nfascbue56 Mutant Phenotype
For in vitro transcription of nfascb full length mRNA, nfascb cDNAwas cloned from pCRII-nfascb into the pCS2+ vector via restriction
digest with EcoRI followed by T4 (NEB Biolabs, M0202S) ligation. Full length wildtype nfascb mRNA was synthesised from nfascb
cDNA using the Sp6 mMessage mMachine Kit (Invitrogen, 10391175) and the RNA cleaned up using the RNAeasy Mini Kit (Qiagen,
74104). RNA concentration was measured with Nanodrop One/One (Thermo Fisher Scientific) visualised on an agarose gel.
To test whether full-length wildtype nfascbmRNAwould rescue the nfascbue56mutant phenotype, F1 progeny from Tg(mbp:EGFP-
CAAX), nfascbue56/+ parents were injected with 700-pg synthetic nfascbmRNA at the one-cell-stage. Embryos were imaged at 5dpf
and then genotyped for homozygosity of the ue56 mutation.
Morpholino Experiments
To deplete Neurofascin B in embryos, 3ng/ml of ATG- blocking morpholino with the sequence TGACAGGAATCCTCCAACACTTCAT
was injected at the single cell stage into Tg(mbp:EGFP-CAAX) for whole spinal cord analysis or Tg(sox10:KaltA4), Tg(UAS:mem-GFP)
embryos for time lapse analyses. As controls, siblings from the same clutch were injected with the widely used negative control mor-
pholino sequence CCTCTTACCTCAGTTACAATTTATA, that targets a human beta-globin intron (https://www.gene-tools.com/
content/negative-control-morpholino-oligos). Animals that showed any abnormal morphology were excluded from the analyses.e3 Developmental Cell 51, 1–15.e1–e6, December 16, 2019
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To genotype nfascbue56mutant, heterozygous, andwildtype animals, DNA surrounding the location of themutationwas amplified in a
standard PCR reaction using the following primers: 50-TTGCATGCCTGAGCAGAATA-30 and 50-TACTTTCCTCCTCGGCTCCT-30.
The 143 bp PCR product was then digested with DpnII. Wildtype products were digested into 27 bp and 116 bp fragments, while
mutant sequence remained uncut. The PCR products were resolved on a 3% gel.
Genotyping of casprsa12772 mutant, heterozygous and wildtype animals was carried out by amplifying DNA spanning the mutation
using the following primers: 50-TTTCACACCAACAACATGGAA-30 and 50-GGGAAGGGTGGATGGAATAA-3. The 803-bp product was
then digestedwith DdeI.Mutant products were digested into 371 bp and 432 bp fragments, while wildtype sequence remained uncut.
Generation of UAS:nfascb-EGFP-pA
To fuse EGFP to the nfascb C-terminus, we used recombinant PCR. Using Phusion DNA polymerase, we amplified nfascb cDNA us-
ing forward primer 50-GGGGACAAGTTTGTACAAAAAAGCAGGCTGCCACCATGAAGTGTTGGAGGATTCCTGTC-30, which adds an
attB1 sequence and Kozak just before the nfascb ORF (which is underlined), and reverse primer 50-CTCGCCCTTGCTCACCATAG
CAAAAGAGTAGATGGCCACAGGAGATGTGGGCTCAGAG-30, which adds the first 18 bp of the EGFP coding sequence immediately
downstream of the penultimate codon of the nfascb coding sequence (underlined), excluding its stop codon. In parallel we amplified
the EGFP cDNA using forward primer 50-GCCATCTACTCTTTTGCTATGGTGAGCAAGGGCGAGGAGCTGTTCACCGGGGTGG-30,
which adds the last 18 bp of nfascb (prior to the stop codon) upstream of the EGFP coding sequence (underlined); and reverse primer
50-GGGGACCACTTTGTACAAGAAAGCTGGGTTTACTTGTACAGCTCGTCCATGCC-30, which adds an attB2R site just downstream
of stop codon in the EGFP coding sequence (underlined). We purified these primary PCR products and used equimolar amounts of
both as template for the secondary recombinant PCR, using only the attB-containing primers. We then used BP Clonase II to recom-
bine this secondary PCR product with pDONRP4-P1R (plasmid #219 from the tol2kit ((Kwan et al., 2007), http://tol2kit.genetics.utah.
edu/index.php/Main_Page) to generate a Gateway-compatible middle-entry vector pME-nfascbEGFP, whose sequence we verified
by Sanger sequencing. We then recombined a 50-entry vector containing 10 UAS repeats (plasmid #327 from the tol2kit (Kwan et al.,
2007), ME-nfascb-EGFP, a 30-entry vector containing a poly adenylation sequence (plasmid #302 from the tol2kit) and destination
vector pDestTol2pA2 (plasmid #394 from the tol2kit) using LR Clonase II Plus to generate UAS:nfascb-EGFP-pA.
Generation of nfascB-EGFP-UAS-mCherry
We used primers 50- GGGGACAACTTTGTATAGAAAAGTTGAAAAAACCTCCCACACCTCCCCC-30 (containing an attB4 site down-
stream of the polyadenylation sequence) and 50- GGGGACTGCTTTTTTGTACAAACTTGGCCACCATGAAGTGTTGGAG
GATTCCTGTC-30 (which adds an attB1R site upstream of the nfascb coding sequence) to generate 50-entry vector p5E-nfascB-
EGFP-pA, and recombined it using LR Clonase II Plus with middle-entry vector pME-UAS (containing 5 UAS repeats flanked by
an E1bminimal promoter in opposite orientations in a Janus configuration (Kwan et al., 2007)), 30-entry vector p3E-mCherry (plasmid
#386 from the tol2kit) and pDestTol2pA2 to generate the plasmid neurofascin B-EGFP-UAS-mCherry, which allows expression of
both Nfasc B-EGFP and cytoplasmic mCherry in the same cells, under control of Gal4-regulated UAS sequences.
RT-PCR
To test whether nfascbmRNA was present in nfascbue56 homozygous mutants, total RNA was isolated from pooled embryos sorted
at 5dpf for the nfascbue56 mutant phenotype or wildtype embryos, and reverse transcribed using the AccuScript High-Fidelity 1st
Strand cDNA Synthesis Kit (Agilent, 200820). The presence of nfascb transcript within the cDNA pool of nfascbue56 versus wildtype
embryos was then tested by PCR amplification of a 796 bp fragment using the primer Nfascb_179-795_RT_F 50-TCCAGTCTTCA
CATGGACGC-30 and Nfascb_179-795_RT_R 50-CGGAACCGATTTGACCCTGA-30 that bind 179 bp after the start codon of nfascb.
Reverse transcription of part of mbpX3 (NCBI RefSeq XM_002665557.4) mRNA was used as a positive control using the primers
mbpX3_RT_F 50-AGAAAGGGAAAGAGACCCCAC-30 and mbpX3_RT_R 50-GATCGGCTTTCTCCCAGGTT-30, and no added reverse
transcriptase before PCR amplification as negative control for genomic DNA contamination.
FACS and RT-PCR
To perform RT-PCR on total mRNA isolated from only neurons or myelinating glia cells (oligodendrocytes and Schwann cells), cells
were fluorescently sorted from embryos expressing Tg(NBT:DsRed) which labels neurons or Tg(mbp:nlsEGFP) which labels myeli-
nating glia cells. 400 embryos for each group were homogenised and incubated for 5 minutes in Ca2+ -free Ringer’s solution
(116mM NaCl, 2.6mM KCL, 5mM HEPES,pH7) and de-yolked by pipetting (P200). Cell suspensions were then incubated with
trypsin-EDTA (0.25% trypsin, 1mM EDTA, pH8, PBS) and Liberase (1:20, 100mg/ml; Roche, RE05401119001) for 15 minutes at
28.5, while homogenised every 5 minutes with a P1000 pipette. 200–400ml of suspension solution (DMEM, may add: 1% calf
serum/NGS, 0.8mM CaCl2,50U/ml penicillin, 0.05mg/ml streptomycin, PBS) + 30% NGS was added and the cell suspension then
passed through a 40-mm cell strainer (Falcon, 352340 or 352235). The cells were then centrifuged for 5 min at 350g at 4C, the su-
pernatant was removed leaving 100ml of cell suspension, and 1ml of chilled suspension solution was added to the cells and the sus-
pension briefly vortexed. This step can be repeated 2–3 times, passing the freshly suspended cells though a 40-mm cell strainer
before centrifugation. Finally, the cells were suspended in PBS and transferred to a FACS tube on ice.Developmental Cell 51, 1–15.e1–e6, December 16, 2019 e4
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media A (15 mM Hepes (Gibco 15630-056), 25 mM D-glucose (Sigma G8644-100ML) in HBSS 1X (Gibco 14170-088)). Between
10000-20000 myelinating glial cells and 70000–100000 neuronal cells were typically isolated.
Immediately after sorting, RNA was extracted from cell fractions using the RNeasy Plus Micro kit (Qiagen, 74034) and reverse
transcribed using the Superscript II reverse transcriptase (Invitrogen, 10635003) to obtain yields of 1–1.2mg of cDNA. PCR was
then performed on neuron and myelinating glial cDNA pools using primers nfasc_FACS-RT_F 50-GGCCCTCCTAAACCAGACAC-30,
nfasc_FACS-RT_R 50-ATGGGTTTGAAGCGTTGCAC-30 and caspr_FACS-RT_F 50-TTTCCGGAAGAACCGTCTGG-30, caspr_FACS-
RT_ R 50-CTTCCCCCTTGTAGCCTGTG-30 to test for expression in both cell types, and rbfox3a_FACS-RT_F 50-AGGGACCAG
CAGCTTAACAC-30, rbfox3a_FACS-RT_R 50-GCGACTGTAACCTCCTCTGT-30 and myrf_FACS-RT_F 50-AATCGTTCTGGG
GAACTCGG-30, myrf_FACS-RT_R 50-GATCGTTAGCTTGCTGGGGT-30 as controls for purity of neuronal and glia cell fractions,
respectively. rbfox3a is the zebrafish ortholog to pan-neuronal mammalian NeuN gene (ZFIN:ZDB-GENE-111213-1).
Transmission Electron Microscopy
Tissue was prepared for TEM as previously described (Karttunen et al., 2017). Briefly, zebrafish embryos were terminally anaesthe-
tised in tricaine and incubated, with microwave stimulation, first in primary fixative (4% paraformaldehyde + 2% glutaraldehyde in
0.1M sodium cacodylate buffer) and then in secondary fixative (2% osmium tetroxide in 0.1M sodium cacodylate/imidazole buffer).
Samples were then stained en bloc with a saturated uranyl acetate solution and dehydrated in an ethanol series and acetone, both
with microwave stimulation. Samples were embedded in EMbed-812 resin (Electron Microscopy Sciences) and sectioned using a
Reichert Jung Ultracut Microtome. Sections were cut at comparable somite levels by inspection of blocks under a dissection micro-
scope and stained in uranyl acetate and Sato lead stain. TEM images were taken with a Phillips CM120 Biotwin TEM. The Photo-
merge tool in Adobe Photoshop was used to automate image registration and tiling. To assess axon diameter and g-ratio, axonal
areas were measured in ImageJ with and without their myelin sheath, and diameters (daxon and daxon+myelin, respectively) calculated
from the obtained values. G-ratios were calculated by dividing axon diameter, daxon, by the axon + myelin diameter, daxon+myelin.
Single Cell Labeling
To mosaically label oligodendrocytes we injected fertilized eggs with 1.5nl of 15ng/ml pTol2-mbp:mCherry-CAAX plasmid DNA and
50ng/ml tol2 transposasemRNA. Animals were screened at 5dpf for isolated labelled oligodendrocytes and genotyped after imaging.
Transgenic Cell-Type Specific Rescue
To express Nfascb-GFP in individual oligodendrocytes in a nfascbue56mutant background, the nfascbue56 allele was crossed into the
Tg(sox10:KalTA4) and Tg(ClaudinK:Gal4) lines. We injected F1 progeny from Tg(sox10:KalTA4) or Tg(ClaudinK:Gal4), nfascbue56/+
crosses with 1.5nL of 15ng/mL pTol2- UAS:nfascb-EGFP-pA or nfascb-EGFP-UAS-mCherry plasmid DNA and 50ng/ml tol2 transpo-
sase mRNA. Embryos were screened for isolated labelled oligodendrocytes at 5dpf and genotyped for homozygosity of the ue56
mutation after imaging.
Live Imaging
For live imaging by confocal microscopy, embryos were anaesthetised with 600mM tricaine and mounted in 1.5% low melting point
agarose. Z stacks were acquired using a Zeiss LSM880 confocal microscope equipped with an Airyscan Fast module, using a 203
objective (Zeiss Plan-Apochromat 203 dry, NA = 0.8). Z stacks were acquired with an optimal z-step according to the experiment,
e.g. to image through the entirety of a single cell, or the whole spinal cord.
For time-lapse imaging, Tg(sox10:KalTA4,UAS:mGFP) at 2.5 dpf or Tg(mbp:EGFP-CAAX), embryos at 3.5dpf were anaesthetised
with 600mM tricaine and mounted in 1.5% low melting point agarose in plastic petri dishes and immersed in E3 medium. Z stacks
were again acquired using a Zeiss LSM880 confocal microscope equipped with the Airyscan Fast module and a piezo z-drive, which
allowed rapid acquisition of confocal z-stacks. Z stacks were acquired with a z-step between 0.5-1.5 mm and spanned the whole
extent of the spinal cord (in the z-axis) in order to cover any drift in z-direction of the embryo during imaging. Z stacks were acquired
at 2.5-minute intervals for initial investigation of wildtypemyelination and at 10min to 12min intervals for experimental comparison of
control and nfascb-deficient animals. Tg(sox10:KalTA4,UAS:mGFP) control-injected embryosweremounted in the same petri dishes
as nfascb morpholino injected animals to allow concomitant imaging; similarly Tg(mbp:EGFP-CAAX), nfascbue56 or Tg(mbp:EGFP-
CAAX), casprsa12772 mutant embryos were imaged alongside their siblings to control for any session-specific variability that might
have arisen. The temperature throughout imaging was monitored at 26–28.5C. Larvae were checked for good blood circulation
and general health prior to imaging and genotyped where necessary after imaging.
Typically, only one cell per animal was imaged; whenmore than one cell per animal was imaged, data were averaged per individual
animal. All images and movies represent a lateral view of the spinal cord, anterior to the left and dorsal on top.
Image Processing and Analysis
Figure panels were prepared using Fiji and Adobe Photoshop CS6. For figures, maximum-intensity projections of Z stacks were
made using Fiji, and a representative x-y area was cropped. All zebrafish images and movies represent a lateral view of the spinal
cord, anterior to the left and dorsal on top. For most images, processing using Fiji or Adobe Photoshop included only global change
of brightness and contrast; further processing and analysis is as follows.e5 Developmental Cell 51, 1–15.e1–e6, December 16, 2019
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Time lapsemovies were additionally processed using the Zen blue software for time alignment to correct formovement of the embryo
during imaging. To single out individual cells or areas in time lapsemovies, the original stack was duplicated from a ROI over time and
if necessary, cropped in z to eliminate background, or overlaying other cells.
Analysis of cellular attributes at one time point or dynamically over time, such as number of myelin sheaths per cell, number of
myelinated cell bodies per cell, myelin sheath length per cell; as well as sheath formation, growth and retraction over time, and
cell body myelination, was measured manually using Fiji tools in 3D and maximum intensity projections on z-stacks of one time point
and on maximum intensity projections over time for time lapse data, and then quantified in Excel. Fiji counting tools were used to
ensure that each sheath or myelinated cell body per oligodendrocyte was only counted once and if not obvious due to strong pheno-
typic nature, all counts andmeasurements were performed blinded. Time of sheath formation and sheath growthwas calculated from
sheath length measurements in every frame. Only myelin-shaped cellular profiles that were stable on axons for greater than 30 mi-
nutes were considered as sheaths.
Mouse Tissue Preparation and Immunohistochemistry
Spinal cord tissue was collected from P30 wildtype and Nfasc-/-/Nfasc186mice after transcardiac perfusion with 4% paraformalde-
hyde in 0.1-M phosphate buffer pH 7.4 and post-fixed for 1hrs. For Caspr-/- mice, spinal cord was collected at P23 for both wildtype
and mutant mice. The sex of mice was not assessed. After fixation, spinal cord tissue was washed with phosphate buffered saline
(PBS) and then cryoprotected in 25% sucrose in PBS at 4C. Tissue samples were oriented in O.C.T. embedding matrix compound
(CellPath Ltd) and frozen with liquid nitrogen cooled isopentane. The blocks were then stored at -80C until use. Coronal sections
(25 mm) were cut from the cervical spinal cord (C5-C8) using a Leica CM3050 cryostat and collected on SuperFrost Slides
(Thermo Scientific). Sections were dried and stored at -20C until use.
Teased fibers were obtained from the ventral funiculus of the cervical spinal cord using acupuncture needles as described
(Jarjour and Sherman, 2019).
Cryostat sections or teased fibers were blocked in blocking solution (5% fish skin gelatine (Sigma), 0.2% Triton X-100 in PBS) for
1 hrs at room temperature. Primary antibodies were diluted in the same buffer and incubated overnight at room temperature in hu-
midified chambers, followed by PBS washes. AlexaFluor (1:1000) or FITC (1:200)-conjugated secondary antibodies were applied for
1.5 hrs (Molecular Probes, Jackson ImmunoResearch, Southern Biotech). Primary antibodies were used at the following dilutions:
rabbit anti-MBP (1:1000, (Tait et al., 2000) , rabbit anti-Nfasc186 (MNF2 1:1000, (Vouyiouklis and Brophy, 1993)), mouse anti-Caspr
(1:50, kind gift of Dr Matthew Rasband, Baylor College of Medicine,TX), mouse anti-Kv1.1 (1:200, UC Davis/NIH NeuroMab Facility,
K36/15), mouse anti-NeuN (1:500, Millipore, MAB377), mouse anti-NF-200 (1:2000, Sigma N0142). Samples were mounted in Vec-
tashield (Vector Laboratories).
Mouse Spinal Cord Image Acquisition and Analysis
Images of the dorsal hornwere acquired using a Zeiss AxioImager Z1microscope equippedwith an Apotome2 structured illumination
unit and a 203 objective (Zeiss Plan-Apochromat 203 dry, NA = 0.8). Images of neuronal cell bodies were acquired using a confocal
microscopeZeiss LSM880 equippedwith Airyscanner and a 203objective (Zeiss Plan-Apochromat 203dry, NA=0.8). Z stackswere
acquired with a z-step between 0.8 mm according to the experiment. The incidence of wrapped cell bodies (as determined by tight
apposition of NeuN+ cell bodies withMBP throughout individual planes in the z stack) was quantified blinded. The region of the dorsal
horn containing NeuN+ cell bodies (inside the dotted lines in the images) from 10 cervical spinal cord (C5 – C8) hemi-sections was
analysed permouse (n=5). Internodal lengthmeasurementswere obtained as the distance between two nodes identified byNfasc186
immunolabelling. A minimum of 50 internodes were measured per mouse (n=5) using Fiji (Schindelin et al., 2012).
QUANTIFICATION AND STATISTICAL ANALYSES
All graphs and statistical tests were carried out using GraphPad Prism. Data was tested for normal distribution using D’Agostino-
Pearson omnibus test and tested for significance between more than two groups with one-way ANOVA or Kruskal-Wallis test if
data was normally distributed or not, respectively. We also compared between groups using a two-tailed unpaired Student’s
t test or using the Mann-Whitney U test. We considered a difference significant when p < 0.05. Throughout the figures, we indicate
p values as follows: non-significant i.e. p > 0.05 ‘ns,’, p < 0.05, ‘*’ p < 0.01, ‘**’ p < 0.001‘***’ p < 0.0001 ‘****’. Indicated p-values are
from t-test comparisons in all graphs where datasets passed the normality test; when data was clearly not normally distributed, we
indicate the result of the Mann-Whitney U test and data points are displayed with interquartile range rather than standard deviation
(SD) or standard error of the mean (SEM). Throughout the figures, error bars indicate either mean ± SD, or SEM where noted. Details
of statistical tests used, precise p value and n values for each comparison are detailed in Figure Legends.
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